DR. HÖNLE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.85 EUR | -0.25% |
|
-0.75% | +13.43% |
| 02-26 | Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
| 01-25 | Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Evolution of the average Target Price on Dr. Hönle AG
Price target over the last 5 years
History of analyst recommendation changes
4fd8926cfcadc6579aac0eac89ae56fc.38jfFy14-ftQyelx1kFjBSkz_yG1Dn29K2PNKkBPP0o.8qCxWgAU1MsGp7M1lxkaZkRYtRbNYAfoSlKUYAx4CDC6np0uRTmylwaQoA~0decec11f2b154eead9f3304c74fc7da
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.85
EUR
Average target price
29.15
EUR
Spread / Average Target
+46.85%
High Price Target
29.3
EUR
Spread / Highest target
+47.61%
Low Price Target
29
EUR
Spread / Lowest Target
+46.10%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Dr. Hönle AG
| HAUCK & AUFHÄUSER | Tim Wunderlich |
| WARBURG RESEARCH | Malte Schaumann |
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- HNL Stock
- Consensus Dr. Hönle AG
